Project Grant R21MH134174

Award Date 8/15/24
Completion Date 8/14/26
Dollars Obligated $445K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This federal Project Grant award of $430,375.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research by Emory University to investigate neurogenic defects in cellular models of Fragile X Syndrome. The project aims to determine if cyclic AMP signaling is disrupted during early brain development in Fragile X Syndrome and whether targeting the microtubule-associated protein Doublecortin could have therapeutic...
This federal Project Grant award of $414,650.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research on the molecular mechanisms regulating the pace of silent synapse maturation and its impact on neural network refinement in the visual cortex. The project, titled "Mechanisms of Silent Synapse Maturation for Excitatory Network Refinement," aims to uncover signaling pathways that govern the balance between...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,181,744 to The Trustees of the University of Pennsylvania to conduct research on the molecular and neural circuit mechanisms underlying goal-directed dysfunction associated with neurexin1 (NRXN1) genetic mutations. The key objectives are to examine how NRXN1 functions within midbrain dopamine neurons and striatal cholinergic interneurons, and...
This federal Project Grant award of $429,000.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to investigate the role of synaptic adhesion molecules in guiding myelin formation on specific axons. The project aims to create new tools for visualizing gene expression and protein localization in living zebrafish models, as well as generate loss-of-function mutations in oligodendrocytes to determine if...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This is a $3,498,931 Project Grant awarded on January 15, 2025 by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant supports the "Cross Scale Interrogation of NPD Genes (SING) in Mice" project, which aims to comprehensively investigate the impact of losing 100 neurodevelopmental and psychiatric disorder (NPD) genes in mice across multiple scales, including gene expression, cellular changes, neural circuits, and...
This federal Project Grant award of $800,485 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to investigate the role of human-specific 3D genome conformation in brain development and disease. The project aims to analyze cortical neural progenitor cells and mature neurons derived from human, chimpanzee, orangutan, and rhesus macaque induced pluripotent stem cells to identify human-specific topologically...
The National Institute of Mental Health (NIMH) awarded a $911,929 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Scripps Research Institute in La Jolla, CA on September 5, 2024. The grant will fund a research project titled "Scalable Functional Analysis of Neuropsychiatric Risk Genes with Spatially Integrated In Vivo Perturb-Seq." The project aims to combine high-content in vivo genetic screening with whole brain cytoarchitecture spatial information to bridge the...
This Project Grant award from the National Institute of Mental Health (NIMH), part of the Mental Health Research Grants federal grant program (CFDA 93.242), provides $267,310 to study the properties and role of dendritic inhibition in the prefrontal cortex of rhesus macaques. The research aims to compare the spatial distribution, kinetics, and synaptic physiology of dendritic inhibition on pyramidal cells in the anterior cingulate cortex (ACC) and lateral prefrontal cortex (LPFC), to elucidate...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 - Mental Health Research Grants supports functional studies of genes associated with neurodevelopmental disorders such as autism, intellectual disability, and schizophrenia. The $742,484 award to the University of Alabama at Birmingham (UAB) will characterize a genetic mouse model to elucidate the function of a gene implicated in these disorders, including examining brain development, behavior,...

This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $445,184 to Trustees of Boston University to explore strategies for rescuing neurological deficits associated with NEXMIF gene haploinsufficiency in female patients. The research aims to investigate the feasibility of reactivating the NEXMIF gene through inhibition of X chromosome inactivation factors, and determine the subsequent effects on neuronal morphology and behavioral deficits in a NEXMIF heterozygous mouse model. The project will span 2 years, from August 2024 to August 2026.

Generated 7/8/25, 2:02 AM